ADDED
Financial Statements (unaudited) 5 Condensed Balance Sheets 5 Condensed Statements of Operations and Comprehensive Loss 7 Condensed Statements of Changes in Convertible Preferred Stock and Stockholder s Equity ( D e f i c i t ) 8 Condensed Statements of Cash Flows 10 Notes to the Unaudited Condensed Financial Statements 12 Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations 20 Item 3.
Exhibits 83 Signatures 85 SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS This Quarterly Report on Form 10-Q for the quarter ended September 30, 2025 contains forward-looking statements.
All statements other than statements of historical facts contained in this Quarterly Report on Form 10-Q, including but not limited to statements regarding our future results of operations and financial condition, our business plans and strategy, the potential market size, market trends and growth opportunities for our products, macroeconomic and geopolitical conditions, and the sufficiency of our cash balances, working capital and cash generated from our operations, investing and financing activities for future liquidity and capital resource needs, may be forward-looking statements.
In some cases, you can identify forward-looking statements by terms such as may, will, would, should, expects, plans, anticipates, could, intends, targets, projects, contemplates, believes, estimates, forecasts, predicts, potential or continue or the negative of these terms or other similar expressions that convey uncertainty of future events or outcomes, although not all forward-looking statements contain these identifying words.
Moreover, we operate in a very competitive and rapidly changing environment, and new risks emerge from time to time.
Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained in this Quarterly Report on Form 10-Q, whether as a result of any new information, future events or otherwise.
Shoulder Innovations, the Shoulder Innovations logos, and other trade names, trademarks, or service marks of Shoulder Innovations appearing in this Quarterly Report on Form 10-Q are the property of Shoulder Innovations.
Other trade names, trademarks, or service marks appearing in this Quarterly Report on Form 10-Q are the property of their respective holders.
We do not intend our use or display of other companies trade names, trademarks, or service marks to imply a relationship with, or endorsement or sponsorship of us, by these other companies.
REMOVED
Financial Statements (unaudited) 5 Condensed Balance Sheets (unaudited) 5 Condensed Statements of Operations and Comprehensive Loss (unaudited) 7 Condensed Statements of Changes in Convertible Preferred Stock and Stockholder s Deficit (unaudited) 8 Condensed Statements of Cash Flows (unaudited) 9 Notes to the Unaudited Condensed Financial Statements 10 Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations 18 Item 3.
Exhibits 81 Signatures 83 FORWARD-LOOKING STATEMENTS This Quarterly Report on Form 10-Q for the quarter ended June 30, 2025 contains forward-looking statements.
All statements other than statements of historical facts contained in this Quarterly Report on Form 10-Q may be forward-looking statements.
In some cases, you can identify forward-looking statements by terms such as may, will, should, expects, plans, anticipates, could, intends, targets, projects, contemplates, believes, estimates, forecasts, predicts, potential or continue or the negative of these terms or other similar expressions.
These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements.
Our business is dependent upon the adoption of our implant systems by hospitals, ambulatory surgery centers ( ASCs ), surgeons and patients.
These unaudited condensed financial statements should be read in conjunction with the audited annual financial statements for the year ended December 31, 2024.
In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses requires additional, disaggregated disclosure around certain income statement expense line items.
treasury and government agencies 8,439 Corporate and international bonds 4,142 Total assets $ 8,540 $ 4,142 $ Liabilities: Preferred stock warrant liability $ 1,967 Total liabilities $ 1,967 December 31, 2024 Level 1 Level 2 Level 3 Assets: Cash Equivalents Money market funds $ 85 $ $ Short-term marketable securities at fair value U.S.